Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"? | JAMA Oncol;8(8): 1220-1221, 2022 08 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?

Rala de Paula, Bruno Henrique; Crocamo, Susanne.

Affiliation

Rala de Paula BH; Sarah Cannon Research Institute, London, United Kingdom.
Crocamo S; Breast Cancer Research Unit, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.

JAMA Oncol ; 8(8): 1220-1221, 2022 08 01.

Article in En | MEDLINE | ID: mdl-35708670

Subject(s)

Breast Neoplasms; Breast Neoplasms/drug therapy; Breast Neoplasms/pathology; Female; Humans; Receptor, ErbB-2; Trastuzumab/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States